Vital signs: colorectal cancer screening test use--United States, 2012
- PMID: 24196665
- PMCID: PMC4585592
Vital signs: colorectal cancer screening test use--United States, 2012
Abstract
Background: Strong evidence exists that screening with fecal occult blood testing (FOBT), sigmoidoscopy, or colonoscopy reduces the number of deaths from colorectal cancer (CRC). The percentage of the population up-to-date with recommended CRC screening increased from 54% in 2002 to 65% in 2010, primarily through increased use of colonoscopy.
Methods: Data from the 2012 Behavioral Risk Factor Surveillance System survey were analyzed to estimate percentages of adults aged 50-75 years who reported CRC screening participation consistent with United States Preventive Services Task Force recommendations.
Results: In 2012, 65.1% of U.S. adults were up-to-date with CRC screening, and 27.7% had never been screened. The proportion of respondents who had never been screened was greater among those without insurance (55.0%) and without a regular care provider (61.0%) than among those with health insurance (24.0%) and a regular care provider (23.5%). Colonoscopy was the most commonly used screening test (61.7%), followed by FOBT (10.4%). Colonoscopy was used by more than 53% of the population in every state. The percentages of blacks and whites up-to-date with CRC screening were equivalent. Compared with whites, a higher percentage of blacks across all income and education levels used FOBT.
Conclusions: Many age-eligible adults did not use any type of CRC screening test as recommended. Organized, population-based approaches might increase CRC screening among those who have never been screened. Promoting both FOBT and colonoscopy as viable screening test options might increase CRC screening rates and reduce health disparities.
Figures

Similar articles
-
Factors Associated with Colorectal Cancer Screening among Mississippi Adults: Findings from the Behavioral Risk Factor Surveillance System.South Med J. 2020 Jul;113(7):360-365. doi: 10.14423/SMJ.0000000000001115. South Med J. 2020. PMID: 32617599
-
Trends in colorectal cancer test use among vulnerable populations in the United States.Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1611-21. doi: 10.1158/1055-9965.EPI-11-0220. Epub 2011 Jun 8. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21653643 Free PMC article.
-
Vital signs: colorectal cancer screening among adults aged 50-75 years - United States, 2008.MMWR Morb Mortal Wkly Rep. 2010 Jul 9;59(26):808-12. MMWR Morb Mortal Wkly Rep. 2010. PMID: 20613704
-
Evidence for colorectal cancer screening.Best Pract Res Clin Gastroenterol. 2010 Aug;24(4):417-25. doi: 10.1016/j.bpg.2010.06.005. Best Pract Res Clin Gastroenterol. 2010. PMID: 20833346 Review.
-
Participation in colorectal cancer screening: a review.J Natl Cancer Inst. 1997 Oct 1;89(19):1406-22. doi: 10.1093/jnci/89.19.1406. J Natl Cancer Inst. 1997. PMID: 9326910 Review.
Cited by
-
Effect of Patient-Directed Messaging on Colorectal Cancer Screening: A Randomized Clinical Trial.JAMA Netw Open. 2022 Mar 1;5(3):e224529. doi: 10.1001/jamanetworkopen.2022.4529. JAMA Netw Open. 2022. PMID: 35357457 Free PMC article. Clinical Trial.
-
Colonoscopy Indication Algorithm Performance Across Diverse Health Care Systems in the PROSPR Consortium.EGEMS (Wash DC). 2019 Aug 2;7(1):37. doi: 10.5334/egems.296. EGEMS (Wash DC). 2019. PMID: 31531383 Free PMC article.
-
Cost-utility analysis of colonoscopy or faecal immunochemical test for population-based organised colorectal cancer screening.United European Gastroenterol J. 2019 Feb;7(1):105-113. doi: 10.1177/2050640618803196. Epub 2018 Sep 19. United European Gastroenterol J. 2019. PMID: 30788122 Free PMC article.
-
Characteristics of Advanced Colorectal Cancer Detected by Fecal Immunochemical Test Screening in Participants with a Negative Result the Previous Year.Yonago Acta Med. 2020 Feb 20;63(1):63-69. doi: 10.33160/yam.2020.02.009. eCollection 2020 Feb. Yonago Acta Med. 2020. PMID: 32158335 Free PMC article.
-
MicroRNAs: Clinical Relevance in Colorectal Cancer.Int J Mol Sci. 2015 Nov 25;16(12):28063-76. doi: 10.3390/ijms161226080. Int J Mol Sci. 2015. PMID: 26602923 Free PMC article. Review.
References
-
- U.S. Cancer Statistics Working Group. United States cancer statistics: 1999–2010 incidence and mortality web-based report. Atlanta, GA: US Department of Health and Human Services, National Cancer Institute, CDC; 2013. Available at http://www.cdc.gov/uscs.
-
- Howlader N, Noone AM, Krapcho M, et al., editors. SEER cancer statistics review, 1975–2010. Bethesda, MD: National Cancer Institute; Available at http://seer.cancer.gov/csr/1975_2010/
-
- U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Rockville, MD: U.S. Preventive Services Task Force; 2008. Available at http://www.uspreventiveservicestaskforce.org/uspstf08/colocancer/colors.htm.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical